Pfizer sales force realignment leaves others evaluating size

Share this article:
Pfizer's late 2006 sales force realignment has left the door open for other drug firms to re-evaluate their own resource levels. “Expect to see several companies follow suit in 2007,” marketing information firm Target Rx CEO Mike Luby told MM&M. Luby said pharma companies will also be looking to create the right mix of centralized and localized operations for sales forces in 2007.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions